Medan Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Payyanur, Kerala, India, established in 2013.
2013 Payyanur, Kerala, India Active
Last Updated:
Access Report
About Medan Pharmaceuticals Private Limited

Medan Pharmaceuticals Private Limited, a active private limited company, was established on 18 November 2013 in Payyanur, Kerala, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U52100KL2013PTC035434. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹3.10 M and a paid-up capital of ₹3.10 M.

It upholds a compliant status. Employing 15 professional, Its leadership includes Kalla Veedu Nidhin (Director), Deepa Pattuvanmar Veetil (Managing Director), Vipin Pattuvanmar Veedu (Director). Past directors included Deepa Pattuvanmar Veetil, Rajesh Raghavan. It holds ₹7.20 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Raghavbhavan,Pmc-20/301-1Oppositenewbusstandplot,Mavicherry, Payyanur, Kerala, 670307.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U52100KL2013PTC035434

  • Registration Number

    035434

  • Incorporation Date

    18 November 2013

  • Authorized Capital

    ₹3.10 M

  • Paid-Up Capital

    ₹3.10 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.10 M
  • Paid Up Capital ₹ 3.10 M
  • Company Age 12 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 7.20 M
  • Revenue Growth **** 12.01%
  • Profit Growth **** 124.74%
  • Ebitda **** 252.03%
  • Net Worth 1.93%
  • Total Assets **** 6.36%
Company report

Medan Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medan Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Medan Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Kalla Veedu Nidhin Director 26 Oct 2022 Current
Deepa Pattuvanmar Veetil Managing Director 18 Nov 2013 Current
Vipin Pattuvanmar Veedu Director 26 Oct 2022 Current
Arjun Thekadavan Director 26 Oct 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 28 Nov 2022 Past
Pramod Abcsdd Director 14 Oct 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medan Pharmaceuticals.

Medan Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.01% increase. The company also saw a substantial improvement in profitability, with a 124.74% increase in profit. The company's net worth moved up by a moderate rise of 1.93%.

Medan Pharmaceuticals revenue growth over time
Medan Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 12.01%
*******
*******
*******
*******
Revenue from Operations
*******
 12.01%
*******
*******
*******
*******
Total Assets
*******
 6.36%
*******
*******
*******
*******
Profit or Loss
*******
 124.74%
*******
*******
*******
*******
Net Worth
*******
 1.93%
*******
*******
*******
*******
EBITDA
*******
 252.03%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medan Pharmaceuticals?

Unlock access to Medan Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹7,200,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.45 Cr
  • Punjab National Bank : 0.27 Cr
Latest Charge Details
Date Lender Amount Status
18 Mar 2022 Others ₹4.50 M Open
16 Feb 2016 Punjab National Bank ₹2.70 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Medan Pharmaceuticals?

Medan Pharmaceuticals has a workforce of 15 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medan Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medan Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Medan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Medan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam. was documented.

  • Charges

    The activity A charge with Others of Rs. 4.50 M registered on 18 Mar 2022 with Charge ID 100572711 was modified on 14 Mar 2024. was completed.

  • Director Appointment

    The activity Kalla Veedu Nidhin was appointed as a Director was appointed as a Director on 26 Oct 2022 & has been associated with this company since 3 years 3 months . was completed.

  • Director Appointment

    Progress on Vipin Pattuvanmar Veedu was appointed as a Director was appointed as a Director on 26 Oct 2022 & has been associated with this company since 3 years 3 months . was documented.

  • Director Appointment

    Progress on Arjun Thekadavan was appointed as a Director was appointed as a Director on 26 Oct 2022 & has been associated with this company since 3 years 3 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Medan Pharmaceuticals Private Limited?

The CIN of Medan Pharmaceuticals Private Limited is U52100KL2013PTC035434.

Where is Medan Pharmaceuticals Private Limited headquartered?

Medan Pharmaceuticals Private Limited is headquartered at Raghavbhavan,Pmc-20/301-1Oppositenewbusstandplot,Mavicherry, Payyanur, Kerala, 670307.

When was Medan Pharmaceuticals Private Limited incorporated?

Medan Pharmaceuticals Private Limited was incorporated on 18 November 2013.

Who are the current directors of Medan Pharmaceuticals Private Limited?

The current directors of Medan Pharmaceuticals Private Limited are

What is the primary industry of Medan Pharmaceuticals Private Limited?

The primary industry of Medan Pharmaceuticals Private Limited is Trade.

Is Medan Pharmaceuticals Private Limited a listed company?

Medan Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Medan Pharmaceuticals Private Limited?

The authorized capital of Medan Pharmaceuticals Private Limited is ₹3.10 M, and the paid-up capital is ₹3.10 M.

What is the compliance status of Medan Pharmaceuticals Private Limited?

The compliance status of Medan Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available